Clinical News

Clinical Status

<div class="articleContainer"><div class="articleWrapper"><div class="articleContent"><h1 class="text title">ARX-02: Phase II started</h1><div class="byline">WIR Staff</div><div class="date"></div></div></div></div>

VTJGc2RHVmtYMThaYlhTbnJtS2h6dG51OWlSelVyZFRCbVZGVjFGcjA3eDBOUXB6UlcxdG5QZDlWZHk3L3B1dWhIOThuZ3gzenBscTJIbXRualgwTXdRTjJCUXdWU04rKzBFZ09mbm5zdVhORmU4YU02M25OalJwZzZvU2djWnNzTUhKRGkrTWg5TnN1VmkrcUFraUNQUUx2SlV4NSt0VkFyNVlFbTlmd3dNY09QZVFwMmRjVklYbW5NclN6YjMrdG9TRjlMVW9iV0NOM1lKcU9DSDd2ZHV2L1NjQmNkT1BMV285NjU0aUxyOXVGVkVjaDRKa3RZNFc0WWlJaEJTUHNSR2pSRXY1a0VicXNybm9HYWNOTmhBYnRWd29LdzlZWWpVREdQeHlSQlk1anRoMmFjbnVaT1NvWlhWZW4xbGQvWWJYeXdXRlJ6ZUJxZjQwS3haRXdvWmNWMTRWSC9NOElNdEg3cnovbXE4VGwyVXREY2ZuUTlBU0tuaGRzbHNQOG9tTUdTSGxFZDdoZ3lPL3k4OXNrRUZOaE5UTDhBSHArckFHb1RvMzhuSmFyUFBzMzZqR1VGQUwzNGkvZEhKU0lHSG53NkQzV1poT2JpcmhpdTI0R3owaU9OcTRjL1ZER2I2c0xRTlFzOTU5N0hjbDZiMldsVzJCK2tpaWh5VjRMRTdDZ1FxQUZ5VlplUHBlLzIwRVhaYjRHNnhDTVNyT3NNM3Jvb21uMGZmd3B5ZFNONFFybGtkSDZMNVlRVWJ0dnRZUTJ3U0d2R2p3cWloQzVQZkdjYkRaV3NQNzc1TW5EYktDWWJmQlJ5OFRhWGkvNlBLVlFwTWMxaXNIMnZCaHVpd2JuY29CK2MrdE9vQ0ZvdUNGWlcyemlKN3dIU3R2SGsvSUxIVUZGSlFHcHVaWFRFcTZoODA2elNFNVRvc2tnT1h4ekJoVC9iSHVkSUMyMlRzOVBJN2M3OFdqbTUzQ0Z6dzBuL2RLMXlraGlaYWRKa093by9xWVRRRFE1RTlicnZ1MnNHUzNpTDBPbXVSY2hoNHRtVHdpQlYvMFVueXJ5ejNEYzJsY0ovOVBEa3F4RlRpMFpRbFZ4bHJrdDJ3dnFta1hMRkFLcEw3c2h0endMMFh5QjB5ejM2T0pMMGZpVWNlTThjcXpYTXJrelh4dzZKWkZQbzgvdmZJMWJZNSs0U1IvTmZoVzAxeHN2bXdxZHNsOU1SYzR3MkQ0UEx2U0UxSXp1U1N2bVM4QldXQlcrQytZQmhUbmNjMWIvaWRjMWtrZnZ1NldCUGcxRDFxSTZoaEdYZVZvZzlpL21pRllFWDJ5YVpoMWw2dUdlSHdlWjBkemJTam1UNm9vY3QzOWsxNXdPSm1PaXRqRWRyZDg4STlFMUo2VWhLdklzREJ3b25UV0Z0Uk50T2l1aTdPZzhraEMzdHJqU1FpdU4wcS9FTFpOai9pazNhbm0xaE9oVk9qWUdKdFcyQUU0amJxT0tOdXN4ckozVlplTmpYNko3T3hXYjlIY2pPWUZDbWN5NkN0N1RFQnRUdE1BOGtSNUNPVkh5NEQ3WnNLbHB1MHJsQXhBUHV6YmdWM0lRV2x5eDlKMFNabnR0VlgrbVQzbjN0ZmNoUUZtOFdQNW9WQ0pGcGVrM3ZEcmdkSGovcnRsS3ovTnJxaHRGWWtocjh4TVRwLzhmRE90QWhuS2NoVzJTQnBBWC9DNU96V3hoSHFxSXB5MlJOZ3l4ZHlqOTdlTmJGNXB6YVlqcTdvYVFkZWRSNjBoYWt6bEt2akZ5WnFJa3ZodDZWSUtUVmVZMlExT0p6cUlOb2piZTR1R1UwdVhRY0FKNitBM0VLRGFsMjB2YUhLd25sZEg1alloOEVpZXN1VjNkd25ZTzJ6NndKOXg2eG11a3c9PQ==

AcelRx began a double-blind, placebo-controlled, crossover Phase II trial to evaluate sublingual ARX-02 in 42 patients. ......

cancer

Neurology

Ophthalmic

ARX-02: Phase II started

Featured Analysis

Articles by Category

Current Editions

Data Graphics

Discovery & Translation Analysis

Discovery & Translation

Hot Topics

BioCentury Podcasts 

Special Reports & Presentations

White Papers

Analysis

BCIQ

Company Profiles

Product Profiles

Target Profiles

Financial Dashboards

BCIQ Data Coverage

BCIQ Data

All Events

BioCentury's JPM Guide 2026

JPM Guide 2026

East-West Healthcare Reception

At the East-West Summit, you will meet key players looking to globalize innovation from across Asia.